Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
AI platform for in silico antibody discovery
Antiverse is a Cardiff-based company using machine learning to identify diverse and rare antibody candidates from next-generation sequencing data of naïve and immune repertoires.…
Synthetic psilocybin therapy for treatment-resistant depression and PTSD
Compass Pathways is a clinical-stage biopharmaceutical company developing synthetic psilocybin-based treatments for mental health conditions. Its lead candidate, COMP360, is a…
Recombinant antibody sequencing, engineering and manufacturing services
Absolute Antibody specialises in recombinant antibody technology, offering sequencing, engineering and production services alongside a catalogue of recombinant antibodies and Fc…
Ex vivo human skin models for pharmaceutical and cosmetic testing
Ten Bio is a contract research organisation providing ex vivo human skin research services to pharmaceutical, cosmetic, and medical device companies. Its patented platform…
Integrated drug discovery CRO specialising in small molecule programmes
Domainex is a contract research organisation providing integrated drug discovery services to pharmaceutical companies, biotechnology firms, patient foundations and academic…
Automated liquid handling and sample management instruments
SPT Labtech is a designer and manufacturer of laboratory automation instruments and consumables for liquid handling, sample preparation, and sample management. Its product…
Virus-like particle vaccine platform for infectious disease and diagnostics
iQur is a London-based biotechnology company developing vaccines using its proprietary tandem core virus-like particle platform. The technology uses the hepatitis B virus core…
AI and photonics platform for personalised drug development
iLoF is a digital health company developing an AI-powered platform that uses proprietary photonics technology to generate optical fingerprints from blood samples, building a…
Oligonucleotide therapeutics designed to upregulate protein expression
Orfonyx Bio is a biotechnology company developing genetic medicines that increase, rather than silence, the expression of therapeutic target proteins. Its platform generates…
NLRP3 inflammasome inhibitors for chronic inflammatory disease
NodThera is a clinical-stage biotechnology company developing potent and selective small molecule inhibitors of the NLRP3 inflammasome for diseases driven by chronic inflammation.…
Novel small-molecule anti-fibrinolytic for acute traumatic and surgical bleeding
ClotProtect Therapeutics is a University of Leeds spin-out developing a first-in-class small molecule anti-fibrinolytic to address acute bleeding following trauma and surgery. The…
Oncolytic adenovirus therapeutics for solid tumour cancer treatment
PsiVac is a UK-based biotechnology company developing oncolytic virus therapeutics for the treatment of cancer. Its patented technology uses genetically modified adenoviruses…